Tissue engineered platforms for studying primary and metastatic neoplasm behavior in bone.

3D tumor model Biomaterials Cancer therapy Mechanical properties Tumor microenvironment

Journal

Journal of biomechanics
ISSN: 1873-2380
Titre abrégé: J Biomech
Pays: United States
ID NLM: 0157375

Informations de publication

Date de publication:
22 01 2021
Historique:
received: 14 08 2020
revised: 02 12 2020
accepted: 11 12 2020
pubmed: 2 1 2021
medline: 28 5 2021
entrez: 1 1 2021
Statut: ppublish

Résumé

Cancer is the second leading cause of death in the United States, claiming more than 560,000 lives each year. Osteosarcoma (OS) is the most common primary malignant tumor of bone in children and young adults, while bone is a common site of metastasis for tumors initiating from other tissues. The heterogeneity, continual evolution, and complexity of this disease at different stages of tumor progression drives a critical need for physiologically relevant models that capture the dynamic cancer microenvironment and advance chemotherapy techniques. Monolayer cultures have been favored for cell-based research for decades due to their simplicity and scalability. However, the nature of these models makes it impossible to fully describe the biomechanical and biochemical cues present in 3-dimensional (3D) microenvironments, such as ECM stiffness, degradability, surface topography, and adhesivity. Biomaterials have emerged as valuable tools to model the behavior of various cancers by creating highly tunable 3D systems for studying neoplasm behavior, screening chemotherapeutic drugs, and developing novel treatment delivery techniques. This review highlights the recent application of biomaterials toward the development of tumor models, details methods for their tunability, and discusses the clinical and therapeutic applications of these systems.

Identifiants

pubmed: 33385867
pii: S0021-9290(20)30613-8
doi: 10.1016/j.jbiomech.2020.110189
pmc: PMC7855491
mid: NIHMS1658592
pii:
doi:

Substances chimiques

Biocompatible Materials 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

110189

Subventions

Organisme : NIDCR NIH HHS
ID : R01 DE025475
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE025899
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM136559
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL086350
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Biomacromolecules. 2016 Nov 14;17(11):3750-3760
pubmed: 27723964
Pediatr Blood Cancer. 2018 Sep;65(9):e27227
pubmed: 29923370
ACS Biomater Sci Eng. 2016 Nov 14;2(11):1968-1975
pubmed: 33440532
Acta Biomater. 2019 Apr 1;88:86-101
pubmed: 30771534
Nano Lett. 2020 Feb 12;20(2):1183-1191
pubmed: 31908168
Biomater Sci. 2019 Jan 29;7(2):618-633
pubmed: 30515503
Nat Cell Biol. 2015 May;17(5):678-88
pubmed: 25893917
Langmuir. 2012 Jan 31;28(4):2028-34
pubmed: 22182057
Sci Adv. 2020 Aug 26;6(35):eabb3308
pubmed: 32923637
J Biomed Mater Res A. 2016 May;104(5):1182-93
pubmed: 26779779
Science. 2016 Apr 15;352(6283):353-8
pubmed: 27013428
Vet Surg. 2017 May;46(4):539-548
pubmed: 28152185
Tissue Eng Part B Rev. 2010 Aug;16(4):371-83
pubmed: 20121414
Sci Rep. 2019 Apr 29;9(1):6597
pubmed: 31036886
Nat Mater. 2012 Jul 01;11(8):734-41
pubmed: 22751180
Biomaterials. 2019 Sep;215:119177
pubmed: 31176804
Biomater Sci. 2020 Mar 31;8(7):1855-1864
pubmed: 32091033
J Cell Biol. 2019 Dec 2;218(12):4093-4111
pubmed: 31690619
J Mech Behav Biomed Mater. 2019 Jan;89:162-167
pubmed: 30286375
J Cell Sci. 2017 Jan 1;130(1):177-189
pubmed: 27505896
Biomater Sci. 2017 Jul 25;5(8):1480-1490
pubmed: 28584885
Ultrasound Med Biol. 2014 Aug;40(8):1755-68
pubmed: 24802305
Mol Pharm. 2014 Jul 7;11(7):2016-21
pubmed: 24754837
ACS Nano. 2017 Dec 26;11(12):12037-12048
pubmed: 29144730
Science. 2020 Oct 30;370(6516):
pubmed: 33122355
Sci Rep. 2018 Mar 28;8(1):5333
pubmed: 29593247
Gels. 2018 Nov 21;4(4):
pubmed: 30674861
J Exp Clin Cancer Res. 2019 Mar 22;38(1):117
pubmed: 30898166
Biotechnol Bioeng. 2019 Nov;116(11):3084-3097
pubmed: 31317530
J Theor Biol. 1982 Nov 7;99(1):31-68
pubmed: 6892044
Cancer Discov. 2014 Sep;4(9):998-1013
pubmed: 25185190
Acta Biomater. 2018 Sep 1;77:85-95
pubmed: 30030173
Elife. 2020 Apr 30;9:
pubmed: 32352379
Oncol Rev. 2017 May 09;11(1):321
pubmed: 28584570
Biochim Biophys Acta Mol Cell Res. 2019 Dec;1866(12):118526
pubmed: 31398408
Oncogene. 2017 Feb 9;36(6):863-874
pubmed: 27499095
Mater Sci Eng C Mater Biol Appl. 2020 Jul;112:110932
pubmed: 32409080
Biomaterials. 2019 Dec;224:119489
pubmed: 31546097
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
PLoS One. 2017 Nov 22;12(11):e0188346
pubmed: 29166651
BMC Med. 2006 Dec 26;4(1):38
pubmed: 17190588
Biofabrication. 2018 Mar 28;10(3):035004
pubmed: 29595143
Cancer Lett. 2017 Mar 1;388:239-248
pubmed: 27965040
Carbohydr Polym. 2014 Dec 19;114:553-557
pubmed: 25263926
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Nat Commun. 2015 Feb 19;6:6364
pubmed: 25695512
Cell Adh Migr. 2018;12(5):472-488
pubmed: 29969940
PLoS One. 2019 May 10;14(5):e0216564
pubmed: 31075118
Pharmaceutics. 2018 Nov 13;10(4):
pubmed: 30428559
J Mater Chem B. 2015 Nov 28;3(44):8650-8658
pubmed: 32262722
Physiology (Bethesda). 2017 Jul;32(4):266-277
pubmed: 28615311
Acta Biomater. 2016 May;36:73-85
pubmed: 26971667
Breast Cancer Res. 2006;8(2):R20
pubmed: 16608535
Cell Cycle. 2018;17(19-20):2360-2373
pubmed: 30304981
Nat Genet. 2017 Nov;49(11):1567-1575
pubmed: 28991255
J Mech Behav Biomed Mater. 2019 Feb;90:226-238
pubmed: 30384218
Matrix Biol. 2015 May-Jul;44-46:184-90
pubmed: 25661772
J Mech Behav Biomed Mater. 2016 Aug;61:208-220
pubmed: 26874251
Biomed Mater. 2017 Aug 21;12(5):055001
pubmed: 28825915
Nat Rev Cancer. 2015 May;15(5):311-6
pubmed: 25907221
Adv Biosyst. 2019 Sep;3(9):e1900128
pubmed: 32648654
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3502-3507
pubmed: 30755531
Exp Cell Res. 2019 May 15;378(2):191-197
pubmed: 30902573
Biomaterials. 2018 Dec;185:310-321
pubmed: 30265900
Biomaterials. 2020 Jul;245:119973
pubmed: 32244091
PLoS One. 2015 Jul 13;10(7):e0132377
pubmed: 26168187
Eur J Cancer. 2019 Nov;121:177-183
pubmed: 31586757
J Cell Sci. 2011 Feb 1;124(Pt 3):369-83
pubmed: 21224397
Cancer Res. 2013 Sep 1;73(17):5315-9
pubmed: 23733750
Biophys J. 2019 May 21;116(10):1803-1814
pubmed: 31076101
Biomaterials. 2015 Jun;52:367-75
pubmed: 25818443
Genes (Basel). 2020 Feb 28;11(3):
pubmed: 32121160
Commun Biol. 2020 Jul 3;3(1):341
pubmed: 32620903
Oncoimmunology. 2017 May 30;6(7):e1331798
pubmed: 28811974
Sci Adv. 2018 Apr 27;4(4):eaas8998
pubmed: 29719868
J Mech Behav Biomed Mater. 2019 Mar;91:54-58
pubmed: 30529987
Nat Mater. 2014 Oct;13(10):970-8
pubmed: 24930031
Math Biosci Eng. 2017 Feb 1;14(1):289-304
pubmed: 27879134
Pharmacol Ther. 2014 Feb;141(2):222-33
pubmed: 24140083
Biomaterials. 2019 Jan;188:130-143
pubmed: 30343256
Nat Rev Cancer. 2010 Jan;10(1):9-22
pubmed: 20029421
Am J Pathol. 2011 Mar;178(3):1221-32
pubmed: 21356373
Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):911-6
pubmed: 22203958
Sci Rep. 2016 Oct 13;6:35367
pubmed: 27734939
Langmuir. 2015;31(1):307-14
pubmed: 25531276
Breast Cancer Res. 2019 Jan 16;21(1):6
pubmed: 30651129
J Mater Chem B. 2017 Apr 14;5(14):2588-2600
pubmed: 32264037
BMC Cancer. 2014 Nov 05;14:813
pubmed: 25374341
J Cell Physiol. 2018 Apr;233(4):3407-3417
pubmed: 28940499
Chemphyschem. 2004 Mar 19;5(3):383-8
pubmed: 15067875
Front Physiol. 2019 Jun 26;10:814
pubmed: 31316395
Neoplasia. 2015 Jan;17(1):1-15
pubmed: 25622895
Biomaterials. 2019 Apr;198:95-106
pubmed: 29759731
Cancer Cell. 2005 Sep;8(3):241-54
pubmed: 16169468
ACS Nano. 2017 Aug 22;11(8):8282-8291
pubmed: 28696653
Biomaterials. 2016 Dec;111:138-148
pubmed: 27728813
Nat Mater. 2021 Apr;20(4):548-559
pubmed: 33257795
Biomacromolecules. 2014 Jun 9;15(6):1955-69
pubmed: 24798476
Nat Commun. 2017 Nov 21;8(1):1651
pubmed: 29162797
Sci Rep. 2016 Jan 22;6:19672
pubmed: 26795068
Sci Rep. 2019 Jul 26;9(1):10877
pubmed: 31350446
Adv Healthc Mater. 2018 Mar;7(6):e1700980
pubmed: 29205942
J Biomech Eng. 2017 Feb 1;139(2):
pubmed: 27760260
Front Oncol. 2018 Sep 05;8:337
pubmed: 30234012
Biophys J. 2014 Dec 2;107(11):2546-58
pubmed: 25468334
Biomed Mater. 2018 Mar 21;13(3):034109
pubmed: 29460842
Mol Imaging Biol. 2020 Oct;22(5):1170-1181
pubmed: 32002763
J Funct Biomater. 2017 Jun 06;8(2):
pubmed: 28587314
Nat Commun. 2017 Jan 27;8:14056
pubmed: 28128198
Intravital. 2012 Jul 01;1(1):32-43
pubmed: 29607252

Auteurs

Victoria L Thai (VL)

Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, United States.

Katherine H Griffin (KH)

Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, United States; School of Veterinary Medicine, University of California, Davis, Davis, CA 95616, United States.

Steven W Thorpe (SW)

Department of Orthopaedic Surgery, UC Davis Health, Sacramento, CA 95817, United States.

R Lor Randall (RL)

Department of Orthopaedic Surgery, UC Davis Health, Sacramento, CA 95817, United States.

J Kent Leach (JK)

Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, United States; Department of Orthopaedic Surgery, UC Davis Health, Sacramento, CA 95817, United States. Electronic address: jkleach@ucdavis.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH